Actin vs Andrew Meds

Neither Actin nor Andrew Meds has an FDA warning letter on record. On compounded semaglutide injection, Actin costs $600 less a year at standing rates: $149 a month against $199 a month at Andrew Meds. It is one of two products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Actin / Andrew Meds

Actin logo

Actin

6.5/10

Andrew Meds logo

Andrew Meds

8.0/10

FDA warning letters
None on record
None on record
Lowest standing price
$149/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
No state list published
All 50 states and DC
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Actin nor Andrew Meds pays us. Links to them earn nothing. Scores: Actin 6.5, Andrew Meds 8.0. How we are paid

What the record shows

  1. 01

    Neither Actin nor Andrew Meds has an FDA warning letter on record.

  2. 02

    Actin names three pharmacies, all 503A. Andrew Meds names three pharmacies, all 503A.

  3. 03

    On compounded semaglutide injection, Actin costs $600 less a year at standing rates: $149 a month against $199 a month at Andrew Meds. It is one of two products the two sell at comparable terms.

  4. 04

    Andrew Meds lists all 50 states and DC. Actin publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Actin

Andrew Meds

Compounded semaglutide injection

$149/moLower

$1,788 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection

$269/moLower

$3,228 a year

$299/mo

$3,588 a year

Price includes
Medication, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None month to month; the longer terms are paid in advance
None on the month-to-month tier; the discounted tier requires 12 months
Refunds
No refunds: the terms make every sale final, including subscription charges.
Not stated
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Actin: October 17, 2026. Andrew Meds: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Actin

6.5/10
  • $600 a year less on compounded semaglutide injection
  • $360 a year less on compounded tirzepatide injection
  • Publishes no state list

The case for Andrew Meds

8.0/10

The record gives Andrew Meds no edge on this pair.

Scores

Actin 6.5 · Andrew Meds 8.0 out of 10. Six weighted parts.

Value25%

7.1A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
9.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

4.5A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Actin vs Andrew Meds: questions

Neither Actin nor Andrew Meds has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Actin names three pharmacies, all 503A. Andrew Meds names three pharmacies, all 503A. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Actin, by $600 a year at standing rates. Actin: $149 a month, about $1,788 a year. Andrew Meds: $199 a month, about $2,388 a year.
Actin states you can cancel at any time; refunds: no refunds: the terms make every sale final, including subscription charges. Andrew Meds states you can cancel at any time.
Neither Actin nor Andrew Meds pays us. Links to them earn nothing. Scores: Actin 6.5, Andrew Meds 8.0.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register